Vanderbilt Vaccine Center (VVC) Archive — Page 11 of 13

U.S. Sen. Lamar Alexander speaks with three Vanderbilt University Medical Center faculty members in a bright facility lobby; one wears a white lab coat, and other visitors and staff stand in the background.
September 24, 2014

Alexander’s visit highlights efforts to confront Ebola

Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.

A graduate researcher in gloves adjusts a multiwell plate inside laboratory equipment while a senior scientist in a white coat observes.
September 18, 2014

Initiative seeks to develop therapies to combat Ebola

Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses.

Portrait of a smiling man wearing a white shirt and yellow patterned tie against a brown background.
September 11, 2014

Engelhardt lands stem cell transplant research grant

Up to 60 percent of patients who receive a stem cell transplant using cells from another donor will develop post-transplant diabetes mellitus, which can increase the rate of complications and death after the procedure.

Stacks of clear laboratory Petri dishes containing blue-stained samples and handwritten markings on a work surface.
May 1, 2014

Cutting-edge research to be showcased in May

Close-up of a female Aedes aegypti mosquito feeding on human skin, with its abdomen distended and visibly red from ingested blood.
April 7, 2014

Vanderbilt Vaccine Center joins global task force to address urgent viral threat

syringe
March 6, 2014

Multi-center effort targets lethal Ebola, Marburg viruses

Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections.